Jamieson Wellness (TSE:JWEL) had its price target increased by National Bank Financial from C$25.00 to C$26.00 in a research report released on Tuesday, BayStreet.CA reports. The brokerage currently has an outperform rating on the stock.
Shares of TSE JWEL opened at C$24.72 on Tuesday. Jamieson Wellness has a 12-month low of C$17.38 and a 12-month high of C$25.55. The stock has a market cap of $907.11 million and a PE ratio of 32.10. The company has a current ratio of 1.94, a quick ratio of 0.88 and a debt-to-equity ratio of 70.37. The company has a 50-day moving average of C$23.84 and a 200 day moving average of C$21.44.
In related news, Senior Officer John Doherty sold 21,000 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of C$23.80, for a total transaction of C$499,800.00. Following the completion of the sale, the insider now owns 15,648 shares of the company’s stock, valued at approximately C$372,422.40.
About Jamieson Wellness
Jamieson Wellness Inc develops, manufactures, distributes, sells, and markets natural health products in Canada and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The company offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and Lorna Vanderhaeghe Health Solutions Inc brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands.
Featured Story: Trading Ex-Dividend Strategy
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.